Navigation Links
Flipping the 'off' switch on cell growth
Date:2/22/2013

A protein known for turning on genes to help cells survive low-oxygen conditions also slows down the copying of new DNA strands, thus shutting down the growth of new cells, Johns Hopkins researchers report. Their discovery has wide-ranging implications, they say, given the importance of this copying known as DNA replication and new cell growth to many of the body's functions and in such diseases as cancer.

"We've long known that this protein, HIF-1α, can switch hundreds of genes on or off in response to low oxygen conditions," says Gregg Semenza, M.D., Ph.D., a molecular biologist who led the research team and has long studied the role of low-oxygen conditions in cancer, lung disease and heart disorders. "We've now learned that HIF-1α is even more versatile than we thought, as it can work directly to stop new cells from forming." A report on the discovery appears in the Feb. 12 issue of Science Signaling.

With his team, Semenza, who is the C. Michael Armstrong Professor of Medicine at the Johns Hopkins University School of Medicine's Institute for Cell Engineering and Institute for Genomic Medicine, discovered HIF-1α in the 1990s and has studied it ever since, pinpointing a multitude of genes in different types of cells that have their activity ramped up or down by the activated protein. These changes in so-called "gene expression" help cells survive when oxygen-rich blood flow to an area slows or stops temporarily; they also allow tumors to build new blood vessels to feed themselves.

To learn how HIF-1α's own activity is controlled, the team looked for proteins from human cells that would attach to HIF-1α. They found two, MCM3 and MCM7, that limited HIF-1α's activity, and were also part of the DNA replication machinery. Those results were reported in 2011.

In the new research, Semenza and his colleagues further probed HIF-1α's relationship to DNA replication by comparing cells in low-oxygen conditions to cells kept under normal conditions. They measured the amount of DNA replication complexes in the cells, as well as how active the complexes were. The cells kept in low-oxygen conditions, which had stopped dividing, had just as much of the DNA replication machinery as the normal dividing cells, the researchers found; the difference was that the machinery wasn't working. It turned out that in the nondividing cells, HIF-1α was binding to a protein that loads the DNA replication complex onto DNA strands, and preventing the complex from being activated.

"Our experiments answered the long-standing question of how, exactly, cells stop dividing in response to low oxygen," says Maimon Hubbi, Ph.D., a member of Semenza's team who is now working toward an M.D. degree. "It also shows us that the relationship between HIF-1α and the DNA replication complex is reciprocal that is, each can shut the other down."


'/>"/>

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine
Source:Eurekalert

Related biology news :

1. Noncoding RNAs offer huge therapeutic and diagnostic potential
2. Get off my lawn: Song sparrows escalate territorial threats - with video
3. Modern growing methods may be culprit of coffee rust fungal outbreak
4. International biodiversity data symposium to mark the kickoff of the EU BON project
5. Tree die-off triggered by hotter temperatures
6. Experimental gene therapy treatment for Duchenne muscular dystrophy offers hope for youngster
7. Changes to DNA on-off switches affect cells ability to repair breaks, respond to chemotherapy
8. Study of human specimen collections in the US offers first look at their huge diversity
9. Dartmouth research offers new control strategies for bipolar bark beetles
10. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
11. Study offers new insights into the mechanics of muscle fatigue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... January 24, 2017 According to a new market ... Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, ... by MarketsandMarkets, the global market is expected to reach USD 71.03 Billion ... 12.4% from 2016 to 2021. Continue Reading ... ...
(Date:1/24/2017)... , Jan. 24, 2017  Bruker today ... a technology leader in the development, manufacture, ... acquisition adds Hysitron,s innovative nanomechanical testing instruments ... microscopes (AFMs), surface profilometers, and tribology and ... position in nanomaterials research markets. Hysitron,s 2016 ...
(Date:1/24/2017)... ... January 24, 2017 , ... Amendia, ... appointment of Steven F. McAllister as Executive Vice President and Chief Financial Officer. ... U.S. and international markets. Beginning his career at Howmedica, Inc., he has since ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... commercially available malaria Plasmodium falciparum culture panels with standard concentrations of histidine rich ... are available in a range of concentrations from six different malaria strains, are ...
Breaking Biology Technology: